18:16 IST
BSE
Annual General Meeting
Bal Pharma Annual General Meeting
Bal Pharma Ltd held its 39th Annual General Meeting on September 24, 2026, where shareholders transacted all business items as per the notice.
Bal Pharma Ltd
- Share price
- ₹97.50
- Market cap
- ₹155.2 Cr
- Revenue (annual)
- ₹311.7 Cr
- Net profit (annual)
- ₹6.28 Cr
- P/E (TTM)
- 21.5×Sector 47.4×
- Promoter holding
- 50.86%+0.00% QoQ
- FII holding
- 0.15%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Annual General Meeting 7Other Announcement 6Management Change 4Financial Results 3Capital Structure Change 3Dividend 2Board Meeting Date 2Price Movement Clarification 1Merger & Restructuring 1Legal & Regulatory 1Fund Raise 1Annual Report 1
Time
7 announcements with these filters
17:20 IST
BSE
Annual General Meeting
Bal Pharma Annual General Meeting
Bal Pharma Limited will hold its 39th Annual General Meeting on September 24, 2026. The record date for the final dividend is September 17, 2026.
16:55 IST
BSE
Annual General Meeting
Bal Pharma Annual General Meeting
Bal Pharma Ltd released the Scrutinizer's Report on postal ballot voting results regarding the proposed preferential issue of 1,000,000 warrants to the promoter.
16:56 IST
NSE
Annual General Meeting
Bal Pharma Annual General Meeting
Bal Pharma Limited has provided shareholders an opportunity to submit comments or modify their votes regarding a recent corrigendum to a previously issued postal ballot notice.
18:25 IST
BSE
Annual General Meeting
Bal Pharma Annual General Meeting
Bal Pharma issued a corrigendum to its Postal Ballot notice, revising the preferential warrant issue price from ₹81 to ₹84 per warrant.
- Value
- ₹8.40 Cr
16:36 IST
BSE
Annual General Meeting
Bal Pharma Annual General Meeting
Bal Pharma issued a Postal Ballot notice for shareholder approval. The agenda includes issuing 10,00,000 warrants to promoters on a preferential basis.
16:21 IST
BSE
Annual General Meeting
Bal Pharma Annual General Meeting
Bal Pharma issued a Postal Ballot Notice to approve a Rs. 8.1 Crore preferential warrant issue to its promoter. Warrants are convertible within 18 months.
- Value
- ₹8.10 Cr
- Execution
- 18 months